B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen-Reference-Cited by-同舟云学术

B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen

Published:2018-10 Issue:4 Volume:49 Page:695-708.e4
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Hong Sheng,Zhang Zhimin,Liu Hongtao,Tian Meijie,Zhu Xiping,Zhang Zhuqiang,Wang Weihong,Zhou Xuyu,Zhang Fuping,Ge Qing,Zhu Bing,Tang Hong,Hua Zhaolin,Hou Baidong

Funder

Strategic Priority Research Program of the Chinese Academy of Sciences

Chinese National 973 Program

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference55 articles.

1. Imaging of germinal center selection events during affinity maturation;Allen;Science,2007

2. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns;Bachmann;Nat. Rev. Immunol.,2010

3. Dendritic cells and the control of immunity;Banchereau;Nature,1998

4. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements;Barnden;Immunol. Cell Biol.,1998

5. B cells extract and present immobilized antigen: implications for affinity discrimination;Batista;EMBO J.,2000

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Posttransplant complications: molecular mechanisms and therapeutic interventions;MedComm;2024-09

2. Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-09

3. Unraveling spontaneous humoral immune responses against human cancer: a road to novel immunotherapies;Journal of Leukocyte Biology;2024-08-27

4. Tertiary lymphoid structures in anticancer immunity;Nature Reviews Cancer;2024-08-08

5. Blunting specific T-dependent antibody responses with engineered “decoy” B cells;Molecular Therapy;2024-08